Safety, tolerability and pharmacokinetics/pharmacodynamics of the adrenomedullin antibody adrecizumab in a first-in-human study and during experimental human endotoxaemia in healthy subjects

Fulltext:
194891.pdf
Embargo:
until further notice
Size:
1.460Mb
Format:
PDF
Description:
publisher's version
Publication year
2018Source
British Journal of Clinical Pharmacology, 84, 9, (2018), pp. 2129-2141ISSN
Publication type
Article / Letter to editor

Display more detailsDisplay less details
Organization
Intensive Care
Internal Medicine
Journal title
British Journal of Clinical Pharmacology
Volume
vol. 84
Issue
iss. 9
Page start
p. 2129
Page end
p. 2141
Subject
All institutes and research themes of the Radboud University Medical Center; Radboudumc 4: lnfectious Diseases and Global Health RIMLS: Radboud Institute for Molecular Life SciencesThis item appears in the following Collection(s)
- Academic publications [227883]
- Electronic publications [107344]
- Faculty of Medical Sciences [86219]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.